Alec van Gelder/LinkedIn
Dec 5, 2025, 06:04
Alec van Gelder: Expanding Global Support for People with Blood Disorder
Alec van Gelder, Vice President of Corporate Affairs, Rare Disease at Novo Nordisk, shared on LinkedIn:
“Congratulations to the Novo Nordisk Haemophilia and Haemoglobinopathies Foundation as you expand your reach to support even more people living with haemophilia, sickle cell disease, and thalassaemia. Wishing the NNHF Council and team continued success as you amplify your impact and shape a brighter future for patients and communities living with blood disorders worldwide.”
Stay informed with Hemostasis Today.
-
Jul 26, 2026, 16:26Novi Yanti Sari: When MPNs Affect the Heart
-
Jul 26, 2026, 16:21Beyond Drugs: Can Museums Become a Medical Prescription?
-
Jul 26, 2026, 14:45Sarah Giorgia Grazia Giannone: An Exciting Chapter in Gene Therapy Research
-
Jul 26, 2026, 14:21Javed Anees: Cerebral Collateral Circulation in Acute Ischemic Stroke
-
Jul 26, 2026, 14:11André Picard։ Canadian Blood Supplies Drop Sharply, Urgent Donor Appeal Issued
-
Jul 26, 2026, 13:54Lorenzo Scalia: New Review Highlights Anticoagulant Strategies for Elderly Patients With Atrial Fibrillation
-
Jul 26, 2026, 13:32Ahmed Kotb: A Practical Guide to Von Willebrand Disease
-
Jul 26, 2026, 12:42Emmanuel J Favaloro: Celebrating Excellence in Scientific Peer Review
-
Jul 26, 2026, 12:20Advancing Sickle Cell Care Through Advocacy – American Society of Hematology